Barclays PLC Alpine Immune Sciences, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$17.75 - $41.6 $552,504 - $1.29 Million
-31,127 Reduced 38.76%
49,170 $1.95 Million
Q4 2023

Feb 15, 2024
BUY
$8.54 - $20.22 $607,800 - $1.44 Million
71,171 Added 779.87%
80,297 $1.53 Million
Q3 2023

Nov 07, 2023
BUY
$10.13 - $13.98 $28,374 - $39,157
2,801 Added 44.28%
9,126 $104,000
Q2 2023

Aug 03, 2023
SELL
$6.84 - $11.91 $39,357 - $68,530
-5,754 Reduced 47.64%
6,325 $65,000
Q1 2023

May 04, 2023
BUY
$7.0 - $8.75 $41,993 - $52,491
5,999 Added 98.67%
12,079 $93,000
Q4 2022

Feb 13, 2023
BUY
$5.45 - $7.35 $29,528 - $39,822
5,418 Added 818.43%
6,080 $45,000
Q3 2022

Nov 03, 2022
SELL
$6.89 - $9.39 $833 - $1,136
-121 Reduced 15.45%
662 $5,000
Q2 2022

Aug 12, 2022
SELL
$6.71 - $9.52 $7,401 - $10,500
-1,103 Reduced 58.48%
783 $7,000
Q1 2022

May 16, 2022
SELL
$6.41 - $13.89 $78,278 - $169,624
-12,212 Reduced 86.62%
1,886 $17,000
Q4 2021

Feb 14, 2022
BUY
$10.41 - $13.95 $97,343 - $130,446
9,351 Added 196.99%
14,098 $196,000
Q3 2021

Nov 09, 2021
BUY
$8.19 - $11.31 $26,846 - $37,074
3,278 Added 223.14%
4,747 $51,000
Q2 2021

Aug 13, 2021
SELL
$8.81 - $15.03 $111,323 - $189,919
-12,636 Reduced 89.59%
1,469 $13,000
Q1 2021

May 13, 2021
BUY
$10.02 - $13.92 $141,332 - $196,341
14,105 New
14,105 $150,000
Q4 2020

Feb 11, 2021
SELL
$7.42 - $15.96 $20,724 - $44,576
-2,793 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$7.15 - $11.5 $19,969 - $32,119
2,793 New
2,793 $25,000
Q4 2019

Feb 10, 2020
SELL
$2.45 - $3.87 $4 - $7
-2 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$3.5 - $5.0 $7 - $10
2 New
2 $0
Q2 2018

Aug 14, 2018
SELL
$7.16 - $10.05 $959 - $1,346
-134 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$7.95 - $11.65 $1,065 - $1,561
134 New
134 $1,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email